LSPRU 13G

Company

ZyVersa Therapeutics, Inc.

Filed

February 3, 2022

Accession Number

0001393825-22-000069

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →